Answers are grounded in this paper and cite their sources.
Background: Stress urinary incontinence (SUI) is a prevalent pelvic floor disorder with significant effects on women's quality of life. While surgical and non-surgical interventions exist, limitations underscore the need for alternative therapies. Injectable platelet-rich plasma (PRP) has emerged as a regenerative approach targeting tissue restoration. This study aimed to systematically evaluate the efficacy and safety of PRP injections for female SUI. Methods: This systematic review and meta-analysis adhered to the PRISMA guidelines. Comprehensive searches of PubMed, Scopus, and Cochrane Library up to April 2025 identified randomized controlled trials (RCTs) and quasi-experimental studies assessing PRP for SUI. The review protocol was prospectively registered in the International Prospective Register of Systematic Reviews (CRD420251118485). Eligible studies reported outcomes on symptom severity, urodynamic parameters, quality of life, or adverse events. Risk of bias was assessed using Cochrane RoB 2.0 for RCTs and the NHLBI tool for before-and-after studies. Pooled effect sizes were calculated using random- or fixed-effects models as appropriate. Quality-of-life scores (IIQ-7, ICIQ-SF) showed consistent improvement. Reported adverse events were mild and self-limiting, with no serious complications observed. Conclusion: Injectable PRP demonstrates promising short-term efficacy in reducing symptoms, improving urodynamic function, and enhancing quality of life in women with SUI, with a favorable safety profile. Larger, standardized RCTs with longer follow-up are needed to validate durability and define its role relative to established therapies. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251118485, CRD420251118485.
No takes yet. Share an insight, caveat, or question.
Utama et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: